Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,145 results that match your search.22,145 results
  • According to the last paragraph of article 78 of the Industrial Property Law (LPI), when resolving a patent invalidity claim, the Mexican Institute of Industrial Property (IMPI) can, besides denying invalidity, declare the whole patent invalid or partial invalidity.
  • Australia has a vibrant life sciences and biotechnology sector supported by a well- regarded IP regime that is evolving rapidly to meet the needs of these new technologies, say James Cherry and Paul Jones of Freehills Patent & Trade Mark Attorneys
  • Of all the IP regimes in Australia, copyright has seen the most dynamic developments and reforms in the last 18 months, particularly in relation to digital technology. Cameron Harvey and David Wilson of Deacons explain what the changes mean for IP owners and users
  • Australia has a robust patent regime that offers effective and potentially broad protection for an ever increasing range of inventions. Scott Berggren, Greg Gurr and Martin O'Brien of Spruson & Ferguson provide answers to some commonly asked questions about patents to help IP owners get the most out of the system
  • IP offices around the world face an ever-growing range of challenges, from responding to calls for harmonization and the surge in demand for IP services to holding on to well-qualified staff to. IP Australia explain their strategy
  • Stéphanie Bodoni, London
  • In May 2003, when India's Patent Act was amended, a new Section 107A was introduced. This provided for a research exemption as an exception to the general rules of patent infringement. Commonly known as a Bolar provision, this research exemption enables a manufacturer of generic drugs to use a patented invention to obtain marketing approval without the patent owner's permission before the patent expires. The generic drug maker can then market their own version of the patented drug as soon as the patent expires.
  • Brand owners are developing ever-more innovative ways of distinguishing their products. But getting legal protection for new kinds of marks can present challenges. Emma Barraclough introduces a survey of seven Asian jurisdictions that asks the questions that IP owners need the answers to
  • Consumer groups argue that parallel trading leads to cheaper prices but trade mark owners say it jeopardizes their long-term relationships with both distributors and consumers. Peter Hallett of Griffith Hack explains what IP owners can do to stop the trade in Australia